Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 86 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 7795208

    Methods of using deacetylase inhibitors to promote cell differentiation and regeneration

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted

  2. US 7794998

    Primate T-lymphotropic viruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted

  3. US 7794714

    Newcastle disease virus monoclonal antibodies

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 14, 2010 · Expires Sep 9, 2030

    granted

  4. US 7790181

    Live attenuated viral vaccines for Eastern Equine Encephalitis virus

    The United States of America as represented by the Secretary of the Army · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  5. US 7790735

    Methanocarba cycloalkyl nucleoside analogues

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  6. US 7790473

    Biofunctionalized quantum dots for biological imaging

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  7. US 7790764

    Biologically active macrolides, compositions, and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  8. US 7790182

    Protein vaccines against poxviruses

    The United States of America as represented by the Secretary of the Army · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  9. US 7790186

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    The United States of America as represented by the Secretary of the Army · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  10. US 7785565

    Metal chelators and methods of their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted

  11. US 7786285

    Recombinant vaccine against botulinum neurotoxin

    The United States of America as represented by the Secretary of the Army · Granted Aug 31, 2010 · Expires Aug 26, 2030

    granted

  12. US 7781445

    Synthesis of indenoisoquinoliniums and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 24, 2010 · Expires Aug 19, 2030

    granted

  13. US 7780966

    Artificial invaplex

    The United States of America as represented by the Secretary of the Army · Granted Aug 24, 2010 · Expires Aug 19, 2030

    granted

  14. US 7776607

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  15. US 7776883

    Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and AIDS related complex (ARC)

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  16. US 7776521

    Coronavirus isolated from humans

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  17. US 7776337

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  18. US 7777019

    Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 17, 2010 · Expires Aug 12, 2030

    granted

  19. US 7771729

    Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant administration of DNA and ALVAC expression vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  20. US 7771715

    Recombinant vector expressing multiple costimulatory molecules and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  21. US 7771956

    Method for detecting the presence of a phospholipid

    The United States of America—Department of Veterans Affairs · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  22. US 7767645

    SH2 domain binding inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted

  23. US 7763719

    Variants of humanized anti-carcinoma MAb CC49

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted

  24. US 7763451

    Methods for preparing Bacillus anthracis protective antigen for use in vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.